Thirteen new cases have been filed in Pennsylvania federal court as part of a multidistrict litigation accusing numerous pharmaceutical companies of conspiring to fix the prices of generic drugs.
Seven more lawsuits have been filed this week as part of a multidistrict litigation that accuses the pharmaceutical companies of conspiring to fix generic drug prices.
Six more lawsuits have been added to a multidistrict litigation that claims various pharmaceutical companies have conspired to fix the price of generic drugs.
Four new complaints have been filed in PA federal court as part of a multidistrict litigation that claims various pharmaceutical companies conspired to fix drug prices.
Two Louisiana insurance companies have jointly filed two different lawsuits against pharmaceutical companies for allegedly conspiring to fix the prices of generic drugs.
Another antitrust lawsuit has been filed against Mylan, its subsidiary, Sandoz, and Taro Pharmaceuticals USA Inc. claiming they conspired to fix generic drug prices.
A lawsuit has been filed against nine pharmaceutical companies and their subsidiaries claiming the companies conspired to fix prices of generic pravastatin sodium.
The Detectives Endowment Association of the City of New York has filed a proposed class action in Pennsylvania against a collection of drug manufacturers.
A proposed class action alleges a who's who of major pharmaceutical companies engaged in a conspiracy to fix the prices of certain generic drugs.
The price of pravastatin tablets was artificially inflated as the result of an alleged price-fixing conspiracy between a group of major drug companies.